Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2007-09-25
2007-09-25
Davis, Zinna N. (Department: 1625)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S349000, C546S269400, C546S297000
Reexamination Certificate
active
10876100
ABSTRACT:
The present invention relates to 5-substituted-4-(substituted)phenylamino-2-pyridone derivatives, pharmaceutical compositions and methods of use thereof.
REFERENCES:
patent: 4166859 (1979-09-01), Stahle
patent: 26 30 060 (1978-01-01), None
patent: 27 50 170 (1978-05-01), None
patent: WO99/01421 (1999-01-01), None
Albert, A., et al., “Triazanaphthalenes. Part II.1Covalent Hydration In 1,4,6-triazanaphthalenes,”J. Chem. Soc., 1963, 5156-5166.
Berge, S., et al., “Pharmaceutical Salts,”Journal of Pharmaceutical Science, 1977, 1-19, vol. 66, No. 1.
Bushweller, J., et al., “Sulfoxide Analogues Of Dihydro- And terahydroprephenate As Inhibitors Of Prephenate Dehydratase,”J. Org. Chem., 1989, 2404-2409, vol. 54, No. 10.
Cory, E., et al., “Protection Of Hydroxyl Groups Astert-Butyldimethysilyl Derivatives,”J. Am. Chem. Soc., 1972, 6190-6191, vol. 94.
Dhanak, D., et al., “Synthesis Of [6] (2,4) Pyridinophanes,”J. Chem. Soc., Perkin Trans. 1, 1987, 2829-2832.
Fey, T., et al., “Improved Methods For Transplanting Split-Heart Neonatal Cardiac Grafts Into The Ear Pinna Of Mice And Rats,”Journal Of. Pharmacological And Toxicological Methods, 1998, 9-17, vol. 39.
Hargreaves, K., et al., “A New And Sensitive Method For Measuring Thermal Nociception In Cutaneous Hyperalgesia,”Pain, 1988, 77-88, vol. 32.
Kayser, V., et al., “Local And Remote Modifications Of Nociceptive Sensitivity During Carrageenin-Induced Inflammation In The Rat,”Pain, 99-107, vol. 28.
Mitsuya, M., et al., “A Potent, Long-Acting, Orally active (2R)-2-[(1R)-3,3-Difluorocyclopentyl]-2-hydroxy-2-phenylacetamide: A Novel Muscarinic M3Receptor Antagonist With High Selectivity For M3over M2Receptors,”J. Med. Chem., 2000, 5017-5029, vol. 43.
Schwab, J., et al., “Pro-And Anti-Inflammatory Roles Of Interleukin-1 In Recurrence Of Bacterial Cell Wall-Induced Arthritis In Rats,”Infection And Immunity, 1991, 4436-4442, vol. 59, No. 12.
Black Shannon Leigh
Kaufman Michael David
Ortwine Daniel Fred
Plummer Mark Stephen
Quin, III John
Davis Zinna N.
Warner-Lambert Company LLC
Yakovleva Galina M.
Zielinski Brian C.
LandOfFree
5-substituted-4-[(substituted phenyl) amino]-2-pyridone... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-substituted-4-[(substituted phenyl) amino]-2-pyridone..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-substituted-4-[(substituted phenyl) amino]-2-pyridone... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3732018